Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes (4-Pack)
Mounjaro (Tirzepatide) 10 mg injection for type 2 diabetes management. Comes in a 4-pack of prefilled syringes. Prescription required. Must be refrigerated.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Mounjaro (Tirzepatide) Injection 10 mg/0.5 mL Prefilled Syringes (4-Pack) is a cutting-edge prescription medication approved by the FDA for the treatment of type 2 diabetes in adults. It is a once-weekly, subcutaneous injection that helps manage blood sugar levels effectively when combined with diet and exercise.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it activates two important hormone pathways to improve insulin sensitivity, reduce glucose production, slow gastric emptying, and curb appetite. This dual-action mechanism provides superior glycemic control compared to traditional GLP-1-only medications and may support significant weight loss in some patients.
Each package contains 4 single-dose prefilled syringes, each delivering 10 mg of tirzepatide in 0.5 mL solution. Designed for convenience and safety, these syringes are ready-to-use and require refrigeration to maintain efficacy.
? Product Features:
Active Ingredient: Tirzepatide
Strength: 10 mg/0.5 mL per syringe
Formulation: Prefilled, single-use syringes
Pack Size: 4 injections per box (4-week supply)
Indication: Type 2 diabetes mellitus in adults
Administration: Subcutaneous (under the skin), once weekly
Storage: Store in a refrigerator between 2°C and 8°C (36°F–46°F); do not freeze
Availability: Prescription only (RX required)
? Benefits of Mounjaro (Tirzepatide):
Improves blood sugar control in type 2 diabetes
Helps reduce A1C levels effectively
Once-weekly injection for ease of use
Dual hormone pathway for enhanced glucose regulation
May promote weight loss as an added benefit
Prefilled syringes eliminate dosing errors
⚠️ Important Safety Information:
Not for use in people with type 1 diabetes or for the treatment of diabetic ketoacidosis
Do not use if you or your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Must be prescribed and monitored by a licensed healthcare provider
Common side effects include nausea, vomiting, diarrhea, decreased appetite, and constipation
Serious risks may include pancreatitis, kidney problems, and gallbladder issues



















Reviews
There are no reviews yet.